Konu "Cancer" için Farmasötik Biyoteknoloji Anabilim Dalı listeleme
Toplam kayıt 1, listelenen: 1-1
-
Development of paclitaxel-loaded liposomal systems with anti-her2 antibody for targeted therapy
(Pharmacotherapy Group, 2016)Purpose: To develop liposome formulations containing monoclonal antibody anti-HER2 (MabHer2), and Paclitaxel (PTX). Methods: Seven different liposomal systems containing PTX, or MabHer2 or a combination of PTX and MabHer2 ...